Report - (Neo)adjuvant Immunotherapy: The Next Step in Curing Cancer...Immunotherapy Targeted Therapy Pathologic Complete Response (pCR) 38% 47% 12m PFS 83% 65% pCR Recurrences 0 /51 7/17 Non-pCR

Please pass captcha verification before submit form